HDL and atherosclerosis – the end of the road for therapeutic strategies that increase HDL?
HDL and atherosclerosis
Prof Juan Carlos Kaski
Professor of Cardiovascular Science, Cardiovascular and Cell Sciences Research Institute,St George’s, University of London, UK
Prof Gillian W. Cockerill
Professor of Vascular Biology, St George's, University of London, Head of the Vascular Biology Research Centre at St George's Hospital, University of London, London, UK
Related articles
09/17/2018 - CANTOS One-Year Later - Prof Paul Ridker, Harvard Medical School, USA
09/12/2018 - CANTOS Update: IL-6 inhibition reduces atherothrombotic events - Sian Claire Owen, medical journalist for Cardio Debate, UK
06/11/2018 - Green tea contains compound that reduces risk of atherosclerosis - Sian Claire Owen, medical journalist for Cardio Debate, UK
02/01/2016 - HDL and Cardiovascular Risk - Prof Gillian Cockerill, St George's Hospital University of London, UK
01/21/2016 - Advances in the Management of Dyslipidaemia (Part 3 of 3) - Prof Julian Halcox, Professor of Cardiology, Swansea University College of Medicine, UK
01/21/2016 - Advances in the Management of Dyslipidaemia (Part 2 of 3) - Prof Julian Halcox, Professor of Cardiology, Swansea University College of Medicine, UK
01/18/2016 - Platelets in Atherogenesis & Acute Coronary Syndrome - Professor Albert Ferro, King's Colllege London and Guy's & St Thomas' Hospitals, London, UK
Leave a Reply
You must be logged in to post a comment.